Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SP KT BJURO
Original Assignee
SP KT BJURO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SP KT BJUROfiledCriticalSP KT BJURO
Priority to ES488626ApriorityCriticalpatent/ES488626A0/es
Publication of ES8103163A1publicationCriticalpatent/ES8103163A1/es
Publication of ES488626A0publicationCriticalpatent/ES488626A0/es
Preparation Of Compounds By Using Micro-Organisms
(AREA)
Micro-Organisms Or Cultivation Processes Thereof
(AREA)
Abstract
PROCEDIMIENTO PARA LA OBTENCION DE UNA PREPARACION BIOLOGICA PARA LA ESTIMULACION DE LA ACTIVIDAD VITAL. SE FERMENTA UN MEDIO NUTRIENTE QUE CONTENGA FUENTES DE CARBONO, NITROGENO, SALES MINERALES Y COMPUESTOS BIOLOGICAMENTE ACTIVOS POR MEDIO DE UNA LEVADURA DE BACTERIAS TERMOFILAS DEL GENERO <<LACTOBACTERIUM>>, <<STREPTOBACTERIUM>>, BACTERIAS MESOFILAS DEL GENERO <<STREPFOCOCCUS>>, <<AZOBACTERIUM>>, <<SHERMANNI>>, <<BACTERIUM ACIDI PROUIONICUM>>, <<ESCHERICHIA COLI>>, <<PSEUDOMONAS>>, A UNA TEMPERATURA ENTRE -5 Y +15GC DURANTE UN PERIODO DE 1 A 1,5 DIAS Y A UNA TEMPERATURA ENTRE 20 Y 50GC DURANTE 1 O 1,5 DIAS.
ES488626A1980-02-151980-02-15Un procedimiento para la obtencion de una preparacion biolo-gica para la estimulacion de la actividad vital
GrantedES488626A0
(es)
1,4-dioxido-2-cyanoalkylcarboxamide-3-methyl-quinoxaline derivatives,their manufacture and their use for controlling pathogenic microorganisms and for stimulating growth of animals
Composition with growth regulating activity, the use of said composition in agriculture and horticulture, and novel hexahydropyrimidine-and imidazolidine compounds